Targeted gene delivery to the tissue of interest by recombinant adenovirus (Ad) 
Introduction
Recombinant adenovirus (Ad) vectors are widely used in preclinical and clinical gene therapy. [1] [2] [3] However, one of the limitations in the use of Ad vectors for gene transfer is their non-specific distribution in tissue after in vivo gene transfer. This property imposes an increased risk of unwanted side-effects of the gene therapy procedure due to the vector dissemination, even when Ad vectors are locally administered to the tissue of interest. Vector targeting to a specific tissue or a cell type would enhance gene therapy efficacy and permit the delivery of lower does, which should result in reduced side-effects.
Ad infection of susceptible cells requires two distinct steps. In the first step, the high-affinity binding of the virus to the primary receptor, the coxsackievirus and adenovirus receptor (CAR), on the cell surface occurs via the C-terminal knob domain of the fiber protein. [4] [5] [6] In the 
grin-binding ablated Ad vectors maintained at least 76% of gene transfer activity into cultured CAR-positive cells. Inclusion of the RGD peptide into the HI loop of the fiber knob of CAR-binding ablated Ad vectors restored gene transfer activity in vitro. On the other hand, systemically administered CAR-binding ablated Ad vectors, as well as ␣v integrin-binding ablated Ad vectors mediated similar levels of gene transfer into mouse liver with the conventional Ad vectors. These results suggest that continued interaction of either the fiber with CAR or the penton base with ␣v integrin offers an effective route of virus entry into mouse liver in vivo. Inhibition of the interaction of both the fiber with CAR and the penton base with ␣v integrin is likely to be crucial to the development of targeted Ad vectors.
Gene Therapy (2002) 9, 769-776. DOI: 10.1038/sj/gt/3301701 second step, interaction between the RGD motif of the penton bases with secondary host cell receptors, ␣v␤3 and ␣v␤5 integrins, facilitates internalization of the virus via receptor-mediated endocytosis. [7] [8] [9] Therefore, the interactions of the fiber knob with CAR and the RGD motif of the penton bases with ␣v integrin on the cell are the key mediators by which the Ad vector enters the cells. CAR-and/or ␣v integrin-binding ablated Ad vectors would be required for the development of an effective targeting strategy. Mutation of the AB, DE or FG loop of the fiber knob was reported to abolish the fiber-CAR interaction. [10] [11] [12] In this study, to examine the role of the interaction of the fiber knob with CAR and the RGD motif of the penton bases with ␣v integrin on the gene transfer, we generated CAR-binding ablated and ␣v integrin-binding ablated Ad vectors. Recently, two groups reported that CAR-binding ablation does not change the biodistribution and toxicity of Ad vectors (they examined the characteristics of only CAR-binding ablated Ad vectors). 13, 14 15 reported that mutation of AB loop of the fiber knob (R412S, A415G, E416G and K417G) causes a 10-to 20-fold reduction in transgene expression in the liver. In this study, we mutated the FG loop of the fiber knob to abolish the binding to CAR. For ␣v integrin-binding ablated Ad vectors, the RGD motif of the penton bases was deleted. In addition to the CAR-binding ablated or ␣v integrin-binding ablated Ad vectors, we also examined gene transfer properties of conventional Ad vectors and CAR-binding ablated Ad vectors, both of which contain RGD peptide in the HI loop of fiber knob. We analyzed the transduction efficiency into various types of cultured cells, including CAR-positive and CAR-negative cells, and systemic gene transfer properties in mice in vivo by these types of Ad vectors and compared what we observed to the properties of conventional Ad vectors.
Results
This study was undertaken to examine the contribution of Ad primary and secondary receptors, CAR and ␣v integrin, respectively, to gene transfer into cultured cells, including CAR-positive and CAR-negative cells, and mice in vivo. To do this, CAR-binding ablated (Ad/⌬F-L2) and ␣v integrin-binding ablated Ad vectors (Ad/⌬P-L2) expressing luciferase were generated by mutating the FG loop of the fiber knob 11 and deleting the RGD motif of the penton bases, respectively. The Ad vectors used in this study are summarized in Table 1 .
Gene transfer into cultured cells
First, we compared the gene transfer activity into various types of human cell lines by Ad/⌬F-L2 and Ad/⌬P-L2, with the activity of conventional Ad vectors Ad-L2 ( Figure 1 ). SK HEP-1 and LN319 cells are CAR-positive, while SF295 and LN444 cells are CAR-negative. All cell types expressed ␣v integrin. [16] [17] [18] Ad-L2, the conventional Ad vectors containing wildtype fiber and penton base, mediated efficient gene transfer into SK HEP-1 and LN319 cells (Figure 1a and b) . In contrast, luciferase production in LN444 and SF295 cells transduced with Ad-L2 was over 2-3 log orders lower than that in SK HEP-1 and LN319 cells transduced with Ad-L2 (Figure 1c and d) , suggesting that sufficient expression of CAR on the cell is required for efficient gene transfer by conventional Ad vectors, as described previously. [4] [5] [6] 17, 18 (Note that SK HEP-1 and LN319 cells were transduced with 300 VP/cell of each vector, while LN444 and SF295 cells were transduced with 3000 VP/cell of each vector because of the low levels of luciferase production in the cells transduced with 300 VP/cell of each vector.)
Ad/⌬F-L2 mediated decreased luciferase production In case of CAR-negative and ␣v integrin-positive LN444 cells, recombinant fiber knob did not decrease Ad-L2-and Ad/⌬F-L2-mediated gene transfer, but recombinant penton base decreased both types of gene transfer (Figure 2b-1, b-2) , suggesting that the infection of both Ad-L2 and Ad/⌬F-L2 into LN444 cells is mainly through the interaction of the RGD motif of penton base with ␣v integrin. An inhibition experiment using Ad/⌬P-L2 and LN444 cells could not be performed due to the low expression of luciferase. (Ad/⌬P-L2 contains wild-type fiber knob but not the RGD motif of the penton base, while LN444 cells express ␣v integrin, but not CAR. Therefore, there is no molecule to mediate between Ad/⌬P-L2 and LN444 cells with high affinity.) Taken together, these results suggested that CAR-and ␣v integrin-binding ablated Ad vectors indeed do not bind with CAR and ␣v integrin, respectively, and that Ad infection could be penton base (RGD motif)-␣v integrin mediated, as well as fiber-CAR mediated.
Figure 1 Comparison of luciferase production in several human cells transduced with Ad-L2, Ad/⌬F-L2 and Ad/⌬P-L2. SK HEP-1 (a), LN319 (b), LN444 (c) and SF295 cells (d) were transduced with 300 or 3000 VP/cell (300 VP/cell for SK HEP-1 and LN319 cells; 3000 VP/cell for LN444 and SF295 cells) of Ad-L2, Ad/⌬F-L2 and Ad/⌬P-L2 for 1.5 h. LN444 and SF295 cells were transduced with higher concentrations of Ad vectors due to the insufficient CAR expression. Forty-eight hours later luciferase production was measured by luminescent assay. All data represent the mean ± s.d. of four experiments. n.d., not detectable. SK HEP-1 and LN319 cells are CAR-positive, while LN444 and SF295 cells are CAR-negative.
To develop the targeted Ad vectors, the addition of foreign peptide having affinity to cellular receptor, as well as ablation of CAR and ␣v integrin binding is crucial. As a model, the RGD peptide, which binds with high affinities to integrins (␣v␤3 and ␣v␤5) on the cell surface, 19 was introduced into the HI loop of the fiber knob of conventional Ad vectors and CAR-binding ablated Ad vectors (resulting in Ad vectors AdRGD-L2 and Ad/⌬F-RGD-L2, respectively). Gene transfer activity of Ad-L2, AdRGD-L2, Ad/⌬F-L2 and Ad/⌬F-RGD-L2 was compared in SK HEP-1, LN319, LN444 and SF295 cells ( Table  2 ). Inclusion of RGD peptide into the fiber knob of both conventional and CAR-binding ablated Ad vectors increased luciferase production in all cell types. The effect of inserted RGD peptides on enhanced gene transfer of CAR-binding ablated Ad vectors (Ad/⌬F-L2 versus Ad/⌬F-RGD-L2) was much more striking in the CARnegative cell lines LN444 and SF295 cells. However, AdRGD-L2 showed far better transduction in LN444 and SF295 cells than Ad/⌬F-RGD-L2. Mutation of the FG loop may alter the structure of the fiber such that the RGD peptides is not presented and/or used in an optimal way. These properties would depend on the inserted peptide sequences. These results suggested that the difference of luciferase production by Ad/⌬F-L2 and Ad/⌬F-RGD-L2 was probably due to the inserted foreign peptides and that Ad/⌬F-RGD-L2-mediated gene transfer is mainly due to the inserted foreign peptides. Table 2 Comparison of luiferase production in various cells transduced with Ad-L2, AdRGD-L2, Ad/⌬F-L2 and Ad/⌬F-RGD-L2
Cell

Ad vectors Luciferase production (% of Ad-L2-mediated value)
AdRGD-L2 55 833 ± 2590 Ad/⌬F-L2 120.5 ± 6.8 Ad/⌬F-RGD-L2 3278 ± 462 SF295 Ad-L2 100.0 ± 9.7 (CAR(Ϫ)) AdRGD-L2 97 221 ± 5102 Ad/⌬F-L2
123.3 ± 9.5 Ad/⌬F-RGD-L2 4862 ± 493 SK HEP-1, LN319, LN444 and SF295 cells were transduced with 300 or 3000 VP/cell (300 VP/cell for SK HEP-1 and LN319 cells; 3000 VP/cell for LN444 and SF295 cells) of Ad-L2, AdRGD-L2, Ad/⌬F-L2 and Ad/⌬F-RGD-L2 for 1.5 h. Forty-eight hours later luciferase production was measured by luminescent assay. All data represent the mean ± s.d. of four experiments. Data were expressed as the percent of Ad-L2-mediated values.
Systemic gene transfer properties of CAR-binding ablated or ␣v integrin-binding ablated Ad vectors
The conventional Ad vector delivers the foreign gene predominantly in the liver after intravenous injection into mice, 20, 21 probably due to both the high levels of CAR and ␣v integrin expression in the liver 5, 6 and the large endothelial pores that allow easy access to the organ. 22 To examine the systemic gene transfer properties of the CAR-binding ablated Ad vectors and ␣v integrin-binding ablated Ad vectors, injections of Ad-L2, Ad/⌬F-L2 and Ad/⌬P-L2 were performed via the tail vein of the mice. AdRGD-L2 and Ad/⌬F-RGD-L2 were also injected ( Figure 3 ).
All types of Ad vectors mediated luciferase production predominantly in the liver. No significant difference in liver transduction was found between Ad-L2, Ad/⌬F-L2 and Ad/⌬P-L2, although Ad/⌬P-L2 mediated about 3.5 times less luciferase production in the liver than Ad-L2. Biodistribution of Ad-L2, Ad/⌬F-L2 and Ad/⌬P-L2 was similar (lung and kidney transduction by Ad/⌬P-L2 was slightly suppressed). In contrast, AdRGD-L2 and Ad/⌬F-RGD-L2 showed about six-and 87-fold reduced transduction in liver, respectively, compared with Ad-L2, and slightly reduced transduction in other organs. The luciferase production in brain and muscle was similar in each vector and was very low, near background levels (data not shown). These results suggested that Ad vectors containing ablation of either CAR or ␣v integrin binding do not sufficiently reduce the liver transduction, and that insertion of an RGD peptide into the HI loop of the fiber knob results in a reduction in transgene expression in liver.
Ad vectors containing RGD peptide agglutinate mouse erythrocytes
To examine why AdRGD-L2 and Ad/⌬F-RGD-L2 showed decreased liver transduction, we measured the HA activity of each vector with mouse erythrocytes (Table 3) . AdRGD-L2 and Ad/⌬F-RGD-L2 mediated lower luciferase production in all organs examined than other vectors (Figure 3 ). Systemically administered Ad vectors provide easy access to erythrocytes. Therefore, we speculated that AdRGD-L2 and Ad/⌬F-RGD-L2 might be taken up in erythrocytes, and thus the total vector amounts delivered to each organ might decrease. The HA activity of each vector with human erythrocytes was also examined.
AdRGD-L2 and Ad/⌬F-RGD-L2 agglutinated mouse erythrocytes, and the HA activity of AdRGD-L2 and Ad/⌬F-RGD-L2 was 240 and 15 HAU/10 10 VP of virus/ml, respectively ( Table 3) . The difference of the HA activity of AdRGD-L2 and that of Ad/⌬F-RGD-L2 may reflect the difference of their gene transfer activity, in that Ad/⌬F-RGD-L2 mediated a decreased luciferase production in CAR-negative cells -SF295 and LN444 cellsmore so than did AdRGD-L2 (Table 2 ). In contrast, the HA activity of Ad-L2, Ad/⌬F-L2, and Ad/⌬P-L2 was not detectable. None of the vectors, including AdRGD-L2 and Ad/⌬F-RGD-L2, agglutinated human erythrocytes. These results suggested that fiber-modified Ad vectors containing RGD peptide agglutinated mouse erythrocytes (but not human erythrocytes).
Next, in order to examine the effect of mouse erythrocytes on the gene transfer of each Ad vector, SK HEP-1 cells were transduced with Ad-L2, Ad/⌬F-L2, Ad/⌬P-L2, AdRGD-L2, or Ad/⌬F-RGD-L2 in the presence of mouse erythrocytes (1%), and luciferase production was then measured. However, luciferase production in the cells transduced with AdRGD-L2 or Ad/⌬F-RGD-L2 as well as Ad-L2, Ad/⌬F-L2, or Ad/⌬P-L2 in the presence of mouse erythrocytes was not changed in the absence of mouse erythrocytes (data not shown). Therefore, the HA activity of AdRGD-L2 and Ad/⌬F-RGD-L2 was not high enough to affect the transduction efficiency in the presence of mouse erythrocytes at least in vitro.
Discussion
As a first step toward the development of targeted Ad vectors, CAR-binding ablated and ␣v integrin-binding ablated Ad vectors were generated and the gene transfer properties of their vectors were examined in various conditions in vitro and in vivo. It seems that CAR-binding ablated Ad vectors were propagated by the direct interaction of the RGD motif of the penton base with ␣v integrin in 293 cells, while ␣v integrin-binding ablated Ad vectors Gene Therapy were propagated by the fiber-CAR interaction. From the data of Figures 1 and 2 , CAR-binding ablated and ␣v integrin-binding ablated Ad vectors did not indeed infect the cells via CAR and ␣v integrin, respectively. Since the virus was not produced by mutating both FG loop of the fiber knob and the RGD motif of the penton base (data not shown), their mutations would almost perfectly block the binding and infectious activity of the virus to 293 cells. Other receptors such as the ␣2 domain of major histocompatibility complex (MHC) class I 23 and heparan sulfate glycosaminoglycans 24, 25 might not contribute to the infectability of 293 cells.
The interaction of the RGD motif of the penton base with ␣v␤3 and ␣v␤5 integrins was reported to facilitate the internalization of the virus via receptor-mediated endocytosis. [7] [8] [9] The data of this study using ␣v integrinbinding ablated Ad vectors suggested, however, that their interaction showed the minimal effect on the overall transduction efficiency, at least under in vitro conditions. Although ␣v integrin mediates internalization of the virus, 4-8 slow uptake of ␣v integrin-binding ablated Ad vectors would occur only via CAR.
Intravenous administration of the conventional Ad vectors delivered more than 90% of the input virus to the liver. 20, 21 This problem of hepatic sequestration should be overcome, if the Ad vectors selectively localize gene expression to the tissue of interest. Zinn et al 26 reported that the liver expresses high levels of CAR mRNA and that recombinant Ad5 fiber knob binds with specific receptor (should be CAR) in liver. Their study suggested that the fiber-CAR interaction might be one of the reasons for the Ad-mediated higher gene transfer into the liver in mice. No liver transduction difference, however, was found between CAR-binding ablated and conventional CAR-binding Ad vectors (Figure 3) . These results are consistent with the recently published reports of Leissner et al 13 and Alemany and Curiel. 14 Since they used Ad vectors containing mutation of the AB or DE loop of the fiber knob and we used vectors containing deletion of the FG loop of the fiber knob, both mutations to abolish CAR-binding mediated a similar pattern of biodistribution in mice. Our results, however, are not consistent with the reports of Einfeld et al, 15 in which CAR-binding ablated Ad vectors containing the mutation of AB loop of the fiber knob exhibited 10-fold decrease in liver transduction than CAR-binding Ad vectors (we discuss this later).
␣v integrin-binding ablated Ad vectors also showed similar liver transduction to the conventional vectors, although they mediated slightly less gene transfer in the lung, liver and kidney than the conventional vectors ( Figure 3 ). This result is also different from the data of Einfeld et al. 15 Liver transduction of their vectors was reduced 20-fold relative to that of conventional vectors. These discrepancy, together with results of CAR-binding ablated vectors, may be due to the difference of injection route of the vectors (they injected vectors intrajugularly, while we injected them intravenously) or vector backbone (their CAR-binding ablated vectors contain HA epitope sequence (SRGFKSYPYDVPDYAG, where the HA epitope is underlined) in the HI loop of the fiber knob, while our vectors contain foreign peptide sequences (SNID) due to the Csp45I and ClaI recognition sequence in the HI loop. Also, the vectors of Einfeld et al contain inserts between residues 543 and 544 of the fiber, while our vectors contain inserts between residues 546 and 547 of the fiber. ␣v integrin-binding ablated vectors of Einfeld et al contain HA epitope sequence in the penton base instead of RGD peptide, while our vectors have just the deletion of RGD peptide in the penton base.
Fechner et al 22 performed quantitative analysis of organ-specific expression of CAR and ␣v integrin in mouse and rat on Ad targeting in vivo, and they showed that neither CAR nor ␣v integrin expression, nor the combination thereof, correlated with vector biodistribution after systemic vector application. They suggested that an anatomical barrier, such as the tightness of basal membrane, might play a major role in vector biodistribution. Considering both their report and the present study, an anatomical barrier as well as the interaction of the fiber with CAR or the penton base with ␣v integrin might be the crucial determinants for the biodistribution of Ad vector after systemic vector application. Since the liver has pores up to 100 nm in diameter and expresses higher levels of CAR mRNA and moderate levels of ␣v integrin mRNA compared with other organs, 5, 6 the Ad vectors would have easy access to the interior of the liver and could infect the cells (eg the hepatocytes) via either CAR or ␣v integrin. Alemany and Curiel reported that CARbinding ablated Ad vectors are cleared slowly from the blood, compared with the conventional vectors.
14 Slow accumulation of CAR-binding ablated Ad vectors (and maybe ␣v integrin-binding ablated vectors as well) into the liver would occur. This could be why both CAR-binding ablated vectors and ␣v integrin-binding ablated vectors showed similar liver transduction with conventional vectors. Doubly-ablated Ad vectors, which no longer infect the cells via CAR and ␣v integrin, might reduce the liver transduction. Other receptors such as the ␣2 domain of major histocompatibility complex (MHC) class I 23 and heparan sulfate glycosaminoglycans 24, 25 might also contribute to the liver transduction.
In contrast to the CAR-binding ablated vectors and ␣v integrin-binding ablated vectors, Ad vectors containing RGD peptide in the fiber knob (both CAR-binding vectors and CAR-binding ablated vectors) mediated a decreased liver transduction in comparison with conventional vectors (Figure 3) . Most other organs also showed decreased transduction. On the other hand, these vectors containing RGD peptide agglutinated mouse erythrocytes (Table 3) . Although the HA activity of the vectors containing RGD peptide did not affect its transduction efficiency in vitro (data not shown), the week affinity of Ad vectors containing RGD peptide in the fiber knob with the erythrocytes in vivo might decrease the vector's access to organs such as the liver, thereby decreasing its transduction efficiency to each organ in vivo (Table 3 , Figure 3) . These results regarding the decreased liver transduction of Ad vectors containing RGD peptide, however, were completely opposite from those described by Reynolds et al, 27 who showed that CAR-binding Ad vectors containing RGD peptide in the fiber knob mediated higher transduction in mice liver, kidney, spleen and lung than did the conventional vector. One difference between our experiment and their experiment is that we injected a constant amount of vector particle (VP) of each vector (3 × 10 10 VP), while they injected each vector with the same p.f.u. titer (1 × 10 9 p.f.u.). Since AdRGD-L2 had a smaller p.f.u.-to-particle ratio than did Ad-L2 (p.f.u.-toparticle ratio was 1:8 for Ad-L2 and 1:33 for AdRGD-L2; thus we injected Ad-L2 at 3.8 × 10 9 p.f.u. and AdRGD-L2 at 9.1 × 10 8 p.f.u.), most of difference between our result and their result can be disregarded. Other explanation of this discrepancy is that the vector backbone is slightly different. Our vector contained three additional amino acids flanking the RGD peptide (RGD, SKCDCRGDCFCD -the additional three amino acids are underlined) due to the additional nucleotides contained within the Csp45I and ClaI recognition sites, 17 although a completely identical RGD peptide sequence (CDCRGDCFC) was inserted into the HI loop of the fiber knob. The precise mechanisms are unknown.
The development of truly targeted Ad vectors requires not only the ablation of native tropism and the generation of a novel tropism to an alternative cellular receptor but also the packaging cell lines, which can support the propagation of both CAR and ␣v integrin-binding ablated Ad vectors. One approach to support the propagation of truly targeted Ad vectors exploits the cell lines that express an artificial receptor molecule, which should not have any natural analogs and should be completely artificial, such as anti-His scFv and anti-HA scFv. 11, 28 In such a system, the targeted Ad vector with a pseudoligand having an affinity to an artificial receptor molecule could be propagated. Roelvink et al 11 first reported that CAR-binding ablated Ad vectors containing HA-tag in the HI loop of the fiber knob could be successfully propagated and showed that their Ad vectors had infectivity into the cells expressing anti-HA scFv, but not into normal cells, although the penton base of their Ad vector is still native. Their group recently reported that Ad vectors containing both CAR-binding ablation and ␣v integrinbinding ablation, which were generated in 293 cells expressing anti-HA scFv, exhibited more than a 700-fold decrease in liver transduction. 15 The development of these systems including the packaging cell lines and doubly ablated vectors should be a first step in the application of the targeted Ad vectors. Identification and incorporation of a foreign ligand (ie peptide), which has high affinity with the specific cellular receptor, into the capsid of doubly ablated Ad vectors would be a next step. Targeting Ad vectors would represent a significant advance in the development of safer and more efficient gene delivery and gene therapy.
In summary, CAR-binding ablated or ␣v integrin-binding ablated Ad vectors are not sufficient to develop the targeted vector to tissues or cells of interest in vivo. Ablation of both CAR and ␣v integrin binding might be crucial to the development of targeted Ad vectors. These studies are underway.
Materials and methods
Cells SK HEP-1 cells 29 (an endothelial cell line derived from human liver) were cultured with Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). Human glioma cell lines LN319 (anaplastic astrocytoma), LN444 (glioblastoma multiforme) and SF295 cells (glioblastoma multiforme) 16 (kindly provided by Dr M Tada, Hokkaido University, Hokkaido, Japan) were cultured with DMEM supplemented with 10% FCS.
Plasmid
The vector plasmid pAdHM26, which we used for the generation of CAR-binding ablated Ad vector, was constructed as described below. pBR-AM8, 17 which contains the ApaI-MunI fragment of an Ad type 5 genome (bp 31 905-32 825) and a Csp45I/ClaI site between positions 32 679 and 32 680 of the Ad genome, was digested with BglI/ClaI and Eco57I/ClaI, and three-piece ligation was performed with oligonucleotide 1 (5Ј-GATCTTACTGAA GGCAA-3Ј) and 2 (5Ј-GCCTTCAGTAA-3Ј), resulting in pBR-AM11. pEco-AM11 was generated by the ligation of the HpaI-MunI fragment of pBR-AM11 and the HpaIMunI fragment of pEco-ITR5, 17 the latter of which contains the right end of the Ad genome (from bp 27 331 to the right end of the genome (⌬bp 28 133-30 818) ). Finally, pAdHM26 was constructed by the ligation of the SrfIClaI fragment of pAdHM15-1 17 and the SrfI-ClaI fragment of pEco-AM11, after which the ClaI site at the right end of the Ad genome was changed into a PacI site by using oligonucleotides 3 (5Ј-CGTTAATTAA-3Ј) (PacI recognition sequences are underlined). pAdHM26 has a complete E1/E3-deleted Ad genome with I-CeuI, SwaI and PI-SceI sites in the E1 deletion region and a Csp45I and ClaI (Dam-methylated) site between positions 32 679 and 32 680 of the Ad genome, which is the HI-loop coding region of the fiber protein. pAdHM26 also has the deletion of the FG-loop coding region of the fiber protein (T489, A490, Y491 and T492 of the fiber protein were deleted).
The vector plasmid pAdHM32, which we used for the generation of ␣v integrin-binding ablated Ad vector, was constructed as described below. pAd22, which contains the PmeI-AscI fragment of the Ad genome (bp 13 255-15 672), was digested with HincII and EagI and ligated with HincII/EagI-digested pHM5.2, which is a derivative of pHM5, 30 resulting in pAd24, which contains the HincIIEagI fragment of the Ad genome (bp 14 383-15 229). pAd24 was then digested with SacII and BssHII and ligated with oligonucleotide 4 (5Ј-GGCAATGCAGCCGGT GGAGGACATGAACGATACATCTAGAGCTGAGGAGA AG-3Ј) and oligonucleotide 5 (5Ј-CGCGCTTCTCCTCAG CTCTAGATGTATCGTTCATGTCCTCCACCGGCTGCAT TGCCGC-3Ј), resulting in pAd25⌬. The RGD peptide motif of the penton base, MNDHAIRGDTFATRAE, was changed into MNDTSRAE in pAd25⌬, as previously described by Wickham et al. 31 Then, the altered sequence containing the penton base was introduced into pAdHM4 by continuous routine plasmid construction using in vitro ligation. The resulting vector plasmid pAdHM32 has a complete E1/E3-deleted Ad genome with I-CeuI, SwaI and PI-SceI sites in the E1 deletion region, wild-type fiber sequence and the deletion of the RGD peptide motif of the penton base.
Vector plasmid pAdHM26-RGD, which contains a mutant fiber-coding sequence containing the RGD peptide, CDCRGDCFC, in the HI loop of the fiber knob, was constructed by the ligation of Csp45I/ClaI-digested pAdHM26 and oligonucleotides 6 (5Ј-CGAAGTGTGAC TGCCGCGGAGACTGTTTCTG-3Ј) and 7 (5Ј-CGCAGAA ACAGTCTCCGCGGCAGTCACACTT-3Ј), as previously described. 17 All mutations of the fiber and penton basecoding sequence were checked by sequencing.
Virus
The Ad vectors were constructed by means of an improved in vitro ligation method described preGene Therapy viously. 30, 32 Luciferase-expressing Ad vector plasmids (pAdHM26-CMVL2, pAdHM32-CMVL2 and pAdHM26-RGD-CMVL2) were constructed by the ligation of ICeuI/PI-SceI-digested pAdHM26, pAdHM32 or pAdHM26-RGD, respectively, with I-CeuI/PI-SceIdigested pCMVL1, 17 in which the luciferase gene is cloned into pHMCMV6. 30 CAR-binding ablated virus, ␣v integrin-binding ablated virus and CAR-binding ablated virus containing RGD peptide in the fiber knob (Ad/⌬F-L2, Ad/⌬P-L2 and Ad/⌬F-RGD-L2, respectively) were generated by the transfection of PacI-digested linearized pAdHM26-CMVL2, pAdHM32-CMVL2 and pAdHM26-RGD-CMVL2, respectively, into 293 cells, and were prepared as described previously. 17 Both CAR and ␣v integrinbinding, conventional virus (Ad-L2) and CAR and ␣v integrin-binding virus containing RGD peptide in the fiber knob (AdRGD-L2) were constructed previously. 17 Determination of virus particle titers was accomplished spectrophotometrically by the method of Maizel et al. 33 Adenovirus-mediated gene transduction into cultured cells SK HEP-1, LN319, LN444 and SF295 cells (1 × 10 4 cells) were seeded into a 96-well dish. On the following day, they were transduced with Ad-L2, Ad/⌬F-L2, Ad/⌬P-L2, AdRGD-L2 and Ad/⌬F-RGD-L2 (300 or 3000 vector particles (VP)/cell) for 1.5 h. Forty-eight hours later, luciferase production in the cells was measured using a luciferase assay system (PicaGene LT2.0; Toyo Inki, Tokyo, Japan). All data in transduced cells were corrected by those in non-transduced cells.
Recombinant fiber knob and penton base
Recombinant Ad type 5 penton base protein was expressed in baculovirus with an N-terminal hexahistidine tag. The penton base-coding sequence was synthesized by PCR on pAdHM4 32 that contains the E1/E3-deleted Ad genome, with the following primers: forward, 5Ј-agt cga att cat gcg gcg cgc ggc gat gta tga g-3Ј (EcoRI site is underlined); reverse, 5Ј-agt cgc ggc cgc tca aaa agt gcg gct cga tag gac-3Ј (NotI site is underlined). PCR products were digested with the EcoRI and NotI and then cloned into the EcoRI/NotI site of pAcHLT-A, which is a baculovirus transfer vector (PharMingen, San Diego, CA, USA). Recombinant penton base protein was expressed in baculovirus-infected Sf9 cells according to the manufacturer's instructions, and it was purified by chromatography on Ni-NTA-Sepharose.
Recombinant Ad type 5 fiber knob protein was constructed previously, using a method similar to that used when constructing recombinant Ad type 5 penton base protein. 18 
Adenovirus-mediated gene transduction in vivo
Ad-L2, Ad/⌬F-L2, Ad/⌬P-L2, AdRGD-L2 and Ad/⌬F-RGD-L2 (3.0 × 10 10 VP) were intravenously injected into C57Bl6 mice (male, 5 weeks, obtained from Nippon, Kyoto, Japan). Forty-eight hours later, the heart, lung, liver, kidney and spleen were isolated and homogenized as previously described. 34 Luciferase production was measured by luminescent assay. Protein content was measured with a BioRad assay kit (BioRad, Hercules, CA, USA), using bovine serum albumin as a standard. Mean background value of luciferase production in each organ has been subtracted from the data.
Hemagglutination assay
A hemagglutination (HA) assay was performed by the method of Mei and Wadell 35 with some modifications. Briefly, freshly drawn heparinized mouse and human erythrocytes were washed three times with PBS (phosphate-buffered saline, pH 7.6) and resuspended to a concentration of 1% (v/v) with PBS. Then, the viruses (Ad-L2, Ad/⌬F-L2, Ad/⌬P-L2, AdRGD-L2 and Ad/⌬F-RGD-L2) were diluted in serial two-fold steps in 96-well plates (round-bottom) containing 25 l PBS. To each dilution, 25 l of a 1% suspension of mouse or human erythrocytes was added. The sedimentation pattern was determined after incubation for 2 h at 4°C. The sedimentation pattern after incubation at 37°C showed similar results with that at 4°C. Data were expressed as hemagglutination unit (HAU)/10 10 VP of virus/ml. HA assays were repeated twice.
